stockrowLifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
Follow LFST
Alert me
LifeStance Health Group, Inc. (LFST) EBITDA
LifeStance Health Group, Inc.'s EBITDA for fiscal 2025 was $79.9M, up 94.9% from $41.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $161.1M. Over the past ten years it has ranged from −$230.4M (fiscal 2021) to $79.9M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. LifeStance Health Group, Inc. ranks 26th of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $79.9M | 94.91% |
| FY2024 | $41.0M | — |
| FY2023 | −$106.6M | — |
| FY2022 | −$139.0M | — |
| FY2021 | −$230.4M | — |
| FY2020 | $47.5M | 115.28% |
| FY2019 | $22.0M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $48.3M | 6.89% |
| Jun 2026 | $45.2M | 25.94% |
| Mar 2026 | $35.9M | 12.83% |
| Dec 2025 | $31.8M | 49.72% |
| 23 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| SGRY Surgery Partners, Inc. compare | $583.3M |
| ACHC Acadia Healthcare Company, Inc. compare | $539.9M |
| PACS PACS Group, Inc. compare | $500.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $479.6M |
| CHE Chemed Corporation compare | $438.8M |
| OPCH Option Care Health, Inc. compare | $408.3M |
| AVAH Aveanna Healthcare Holdings Inc. compare | $307.9M |
| NHC National HealthCare Corporation compare | $190.4M |
| LFST LifeStance Health Group, Inc. | $161.1M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on LFST
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement